- Report
- April 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,443GBP
- Report
- March 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,443GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1775EUR$2,000USD£1,534GBP
- Report
- April 2025
- 200 Pages
Global
From €7056EUR$7,950USD£6,096GBP
- Drug Pipelines
- April 2025
- 240 Pages
Global
From €2663EUR$3,000USD£2,300GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1775EUR$2,000USD£1,534GBP
- Clinical Trials
- April 2025
- 180 Pages
Global
From €2219EUR$2,500USD£1,917GBP
- Drug Pipelines
- April 2025
- 240 Pages
Global
From €2663EUR$3,000USD£2,300GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1775EUR$2,000USD£1,534GBP
- Clinical Trials
- April 2025
- 450 Pages
Global
From €4438EUR$5,000USD£3,834GBP
- Clinical Trials
- April 2025
- 100 Pages
Global
From €1775EUR$2,000USD£1,534GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1775EUR$2,000USD£1,534GBP
- Report
- April 2025
- 200 Pages
Global
From €7056EUR$7,950USD£6,096GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1331EUR$1,500USD£1,150GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1331EUR$1,500USD£1,150GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1331EUR$1,500USD£1,150GBP
- Clinical Trials
- April 2025
- 70 Pages
Global
From €1331EUR$1,500USD£1,150GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1331EUR$1,500USD£1,150GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1331EUR$1,500USD£1,150GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1331EUR$1,500USD£1,150GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more